Global Molecular Point of Care Diagnostics Market

1
The Global Molecular Point of Care Diagnostics
Market To Grow at 14.05 CAGR by 2028
Triton Market Research presents the Global
Molecular Point of Care Diagnostics Market report
segmented by Application (Oncology, Infectious
Disease Hospital-acquired Infections,
Gastrointestinal Infections, Respiratory,
Sexually Transmitted Infections, Prenatal,
Others), by Technology (Isothermal Nucleic Acid
Amplification Technology, Polymerase Chain
Reaction Digital PCR, Real-time PCR, Other), by
End-user (Clinics, Hospital, Diagnostic Centers,
Others), by Geographical Region (North America,
Europe, Asia- Pacific, Latin America, Middle
East and Africa), discussing Porter's Five Force
Analysis, Drivers, Restraints, Challenges,
Vendor Scorecard, Global Market Size, Forecasts
Analysis (2019-2028).
A Triton Market Research report depicts that the
Global Molecular Point of Care Diagnostics Market
is progressing at an annual growth rate of
14.05 in the forthcoming period 2019-2028.
Molecular point of care diagnostics refers to an
assessment of health at a molecular level by
detecting and measuring genetic information in
DNA (deoxyribose nucleic acid) or RNA
(ribonucleic acid). It is very useful in the
detection of multiple defects associated with
gene signatures. Request a Free
Sample https//www.tritonmarketresearch.com/repor
ts/molecular-point-of-care-diagnostics-marketrequ
est- free-sample The wide spreading of
coronavirus has caused an increase in the demand
for diagnostic technologies, which is expected
to push the growth of the molecular point of care
diagnostics market. The growing demand for
advanced healthcare services like non-invasive
diagnosis tests and the rising cases of
2
infectious or communicable diseases also drive
the global market growth. However, the market is
facing the restraint of high capital
requirements. Lack of complex testing centers is
also challenging the market. Asia-Pacific is
anticipated to be the fastest-growing region in
the molecular point of care diagnostics market
in the projected period. The increasing health
awareness among the people, constantly developing
economy and the resultant affordability of the
consumers are the essential factors driving the
regional market growth. North America is likely
to be the largest molecular point of care
diagnostics market over the coming years. The
presence of advanced research and development
projects, particularly in the field of genetics,
is the fundamental driver of the market growth
in the North American region. The key players in
the molecular point of care diagnostics market
are Qiagen, Luminex Corporation, Hologic Inc,
Danaher, DiaSorin SpA, F Hoffmann-La Roche Ltd,
Mesa Biotech, QuantuMDx Group Ltd, Quidel
Corporation, Biomerieux SA, Abacus Diagnostica,
Abbott, Bio-Rad Laboratories Inc, Biocartis and
Spartan Biosciences Inc. Since the market is
dominated by the top five companies, it is
considered consolidated in nature. Companies are
trying to offer advanced products in the market
to retain their position in the global market.
The competition is intense as there is a huge
capital cost involved, making the exit barriers
high. Contact Us sales_at_tritonmarketresearch.com
Phone [phone]